世界のドラベ症候群治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11711)
◆英語タイトル:Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11711
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはドラベ症候群治療の世界市場について調査・分析した資料です。種類別(第一世代薬品(FGD)、第二世代薬品(SGD)、第三世代薬品(TGD))の市場規模、用途別(病院薬局、小売薬局、Eコマース、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ドラベ症候群治療の競争状況、市場シェア
・世界のドラベ症候群治療市場:種類別市場規模 2015年-2020年(第一世代薬品(FGD)、第二世代薬品(SGD)、第三世代薬品(TGD))
・世界のドラベ症候群治療市場:種類別市場規模予測 2021年-2026年(第一世代薬品(FGD)、第二世代薬品(SGD)、第三世代薬品(TGD))
・世界のドラベ症候群治療市場:用途別市場規模 2015年-2020年(病院薬局、小売薬局、Eコマース、その他)
・世界のドラベ症候群治療市場:用途別市場規模予測 2021年-2026年(病院薬局、小売薬局、Eコマース、その他)
・北米のドラベ症候群治療市場分析:米国、カナダ
・ヨーロッパのドラベ症候群治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのドラベ症候群治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のドラベ症候群治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのドラベ症候群治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Biocodex、Epygenix Therapeutics、GW Pharmaceuticals、OPKO Health、Zogenix
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells.
Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include clobazam (Onfi, Frisium) and valproic acid (Depakote, Depakene). Second line treatments include stiripentol (Diacomit), topiramate (Topamax), and the ketogenic diet.

Market Analysis and Insights: Global Dravet Syndrome Treatment Market
The global Dravet Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Dravet Syndrome Treatment Scope and Market Size
Dravet Syndrome Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dravet Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Biocodex
Epygenix Therapeutics
GW Pharmaceuticals
OPKO Health
Zogenix

Market segment by Type, the product can be split into
First-generation Drug (FGD)
Second-generation Drug (SGD)
Third-generation Drug (TGD)
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
E- Commerce
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dravet Syndrome Treatment Revenue
1.4 Market by Type
1.4.1 Global Dravet Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 First-generation Drug (FGD)
1.4.3 Second-generation Drug (SGD)
1.4.4 Third-generation Drug (TGD)
1.5 Market by Application
1.5.1 Global Dravet Syndrome Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 E- Commerce
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Dravet Syndrome Treatment Market Perspective (2015-2026)
2.2 Global Dravet Syndrome Treatment Growth Trends by Regions
2.2.1 Dravet Syndrome Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dravet Syndrome Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Dravet Syndrome Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dravet Syndrome Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Dravet Syndrome Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Dravet Syndrome Treatment Players by Market Size
3.1.1 Global Top Dravet Syndrome Treatment Players by Revenue (2015-2020)
3.1.2 Global Dravet Syndrome Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Dravet Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dravet Syndrome Treatment Market Concentration Ratio
3.2.1 Global Dravet Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Treatment Revenue in 2019
3.3 Dravet Syndrome Treatment Key Players Head office and Area Served
3.4 Key Players Dravet Syndrome Treatment Product Solution and Service
3.5 Date of Enter into Dravet Syndrome Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Dravet Syndrome Treatment Historic Market Size by Type (2015-2020)
4.2 Global Dravet Syndrome Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Dravet Syndrome Treatment Market Size by Application (2015-2020)
5.2 Global Dravet Syndrome Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Dravet Syndrome Treatment Market Size (2015-2020)
6.2 Dravet Syndrome Treatment Key Players in North America (2019-2020)
6.3 North America Dravet Syndrome Treatment Market Size by Type (2015-2020)
6.4 North America Dravet Syndrome Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Dravet Syndrome Treatment Market Size (2015-2020)
7.2 Dravet Syndrome Treatment Key Players in Europe (2019-2020)
7.3 Europe Dravet Syndrome Treatment Market Size by Type (2015-2020)
7.4 Europe Dravet Syndrome Treatment Market Size by Application (2015-2020)

8 China
8.1 China Dravet Syndrome Treatment Market Size (2015-2020)
8.2 Dravet Syndrome Treatment Key Players in China (2019-2020)
8.3 China Dravet Syndrome Treatment Market Size by Type (2015-2020)
8.4 China Dravet Syndrome Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Dravet Syndrome Treatment Market Size (2015-2020)
9.2 Dravet Syndrome Treatment Key Players in Japan (2019-2020)
9.3 Japan Dravet Syndrome Treatment Market Size by Type (2015-2020)
9.4 Japan Dravet Syndrome Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Dravet Syndrome Treatment Market Size (2015-2020)
10.2 Dravet Syndrome Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dravet Syndrome Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Dravet Syndrome Treatment Market Size by Application (2015-2020)

11 India
11.1 India Dravet Syndrome Treatment Market Size (2015-2020)
11.2 Dravet Syndrome Treatment Key Players in India (2019-2020)
11.3 India Dravet Syndrome Treatment Market Size by Type (2015-2020)
11.4 India Dravet Syndrome Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Dravet Syndrome Treatment Market Size (2015-2020)
12.2 Dravet Syndrome Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Dravet Syndrome Treatment Market Size by Type (2015-2020)
12.4 Central & South America Dravet Syndrome Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Biocodex
13.1.1 Biocodex Company Details
13.1.2 Biocodex Business Overview
13.1.3 Biocodex Dravet Syndrome Treatment Introduction
13.1.4 Biocodex Revenue in Dravet Syndrome Treatment Business (2015-2020))
13.1.5 Biocodex Recent Development
13.2 Epygenix Therapeutics
13.2.1 Epygenix Therapeutics Company Details
13.2.2 Epygenix Therapeutics Business Overview
13.2.3 Epygenix Therapeutics Dravet Syndrome Treatment Introduction
13.2.4 Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.2.5 Epygenix Therapeutics Recent Development
13.3 GW Pharmaceuticals
13.3.1 GW Pharmaceuticals Company Details
13.3.2 GW Pharmaceuticals Business Overview
13.3.3 GW Pharmaceuticals Dravet Syndrome Treatment Introduction
13.3.4 GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.3.5 GW Pharmaceuticals Recent Development
13.4 OPKO Health
13.4.1 OPKO Health Company Details
13.4.2 OPKO Health Business Overview
13.4.3 OPKO Health Dravet Syndrome Treatment Introduction
13.4.4 OPKO Health Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.4.5 OPKO Health Recent Development
13.5 Zogenix
13.5.1 Zogenix Company Details
13.5.2 Zogenix Business Overview
13.5.3 Zogenix Dravet Syndrome Treatment Introduction
13.5.4 Zogenix Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.5.5 Zogenix Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Biocodex、Epygenix Therapeutics、GW Pharmaceuticals、OPKO Health、Zogenix

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のドラベ症候群治療市場2026:インサイト・予測(Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。